Femme et Homme
- | Pays :
- Italy
- New Zealand
- United States
- Les 4 autres...
- | Organes : -
- | Spécialités : -
Extrait
Study has two parts: 1. Dose-finding: to determine the maximum tolerated dose (MTD) and to evaluate the safety and tolerability of RAD001 (everolimus , Afinitor®) in combination with BEZ235 in patients with advanced solid tumors. 2. Dose-expansion: to assess safety and tolerability of RAD001 and BEZ235 at the MTD in patients with ER+/HER2- metastatic breast cancer and metastatic renal cell cancer
Critère d'inclusion
- Advanced solid tumors ,Metastatic breast cancer ,Metastatic Renal Cell Carcinoma